Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:ACRS
Tag: NASDAQ:ACRS
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Results of Operations and...
ME Staff 8-k
-
March 18, 2019
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) had its Buy rating reiterated by Cantor...
ME Staff
-
March 15, 2019
0
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Other Events
ME Staff 8-k
-
February 8, 2019
0
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Financial Statements and Exhibits
ME Staff 8-k
-
January 18, 2019
0
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Entry into a Material...
ME Staff 8-k
-
December 3, 2018
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) price target lowered to $34.00 by JMP...
ME Staff
-
October 16, 2018
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) had its Buy rating reiterated by JMP...
ME Staff
-
October 16, 2018
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) price target set to $50.00 by Cantor...
ME Staff
-
August 3, 2018
0
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Results of Operations and...
ME Staff 8-k
-
August 3, 2018
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) had its Buy rating reiterated by Cantor...
ME Staff
-
July 17, 2018
0
1
2
3
4
...
6
Page 3 of 6
